Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
RoActemra 162mg/0.9ml inj pre-filled syringes
1001030W0BBADAD
|
Roactemra | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
RoActemra 162mg/0.9ml solution for injection pre-filled pens
1001030W0BBAEAE
|
Roactemra | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
RoActemra 200mg/10ml concentrate for inf vials
1001030W0BBABAB
|
Roactemra | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
RoActemra 400mg/20ml concentrate for inf vials
1001030W0BBACAC
|
Roactemra | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
RoActemra 80mg/4ml concentrate for inf vials
1001030W0BBAAAA
|
Roactemra | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
Rofecoxib 12.5mg tablets
1001010AFAAACAC
|
Rofecoxib | Rofecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Rofecoxib 12.5mg/5ml oral suspension sugar free
1001010AFAAAAAA
|
Rofecoxib | Rofecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Rofecoxib 25mg tablets
1001010AFAAADAD
|
Rofecoxib | Rofecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Rofecoxib 25mg/5ml oral suspension sugar free
1001010AFAAABAB
|
Rofecoxib | Rofecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Rofecoxib 50mg tablets
1001010AFAAAEAE
|
Rofecoxib | Rofecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Salicylamide 5% / Benzocaine 2% gel
100302000AAAAAA
|
Generic compound preparation BNF 1003020 | Other rubefacient and topical antirheumatic preparations | Musculoskeletal and Joint Diseases | No data available |
|
Salonpas medicated plasters
100302000BBBTA0
|
Proprietary compound preparation BNF 1003020 | Other rubefacient and topical antirheumatic preparations | Musculoskeletal and Joint Diseases | No data available |
|
Sarilumab 150mg/1.14ml inj pre-filled syringes
1001030ADAAAAAA
|
Sarilumab | Sarilumab | Musculoskeletal and Joint Diseases | No data available |
|
Sarilumab 200mg/1.14ml inj pre-filled disposable devices
1001030ADAAADAD
|
Sarilumab | Sarilumab | Musculoskeletal and Joint Diseases | No data available |
|
Sarilumab 200mg/1.14ml inj pre-filled syringes
1001030ADAAABAB
|
Sarilumab | Sarilumab | Musculoskeletal and Joint Diseases | No data available |
|
Secukinumab 150mg/1ml inj pre-filled syringes
1001030AFAAABAB
|
Secukinumab | Secukinumab | Musculoskeletal and Joint Diseases | No data available |
|
Secukinumab 300mg/2ml inj pre-filled disposable devices
1001030AFAAACAC
|
Secukinumab | Secukinumab | Musculoskeletal and Joint Diseases | No data available |
|
Secukinumab 75mg/0.5ml inj pre-filled syringes
1001030AFAAADAD
|
Secukinumab | Secukinumab | Musculoskeletal and Joint Diseases | No data available |
|
Seractil 300mg tablets (Gebro Pharma GmbH)
1001010AMBBACAA
|
Seractil | Dexibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Seractil 300mg tablets (Thornton & Ross)
1001010AMBBAAAA
|
Seractil | Dexibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Seractil 400mg tablets
1001010AMBBABAB
|
Seractil | Dexibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Serrapeptase 5mg gastro-resistant tablets
1003010V0AAAAAA
|
Serrapeptase | Serrapeptase | Musculoskeletal and Joint Diseases | No data available |
|
Simponi 50mg/0.5ml inj pre-filled syringes
1001030X0BBAAAA
|
Simponi | Golimumab | Musculoskeletal and Joint Diseases | No data available |
|
Simponi 50mg/0.5ml solution for injection pre-filled pens
1001030X0BBABAB
|
Simponi | Golimumab | Musculoskeletal and Joint Diseases | No data available |
|
Slo-Indo 75mg capsules
1001010K0BLAAAD
|
Slo-Indo | Indometacin | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.